H.R.5526

Biosimilar Red Tape Elimination Act

Introduced·9/19/25

Prefiled

Introduced9/19/25

Chamber Passed

Final Passage

Complete

Introduced

H. R. 5526

September 19, 2025

Mr. Pfluger (for himself and Mr. Landsman) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To improve the requirements for making a determination of interchangeability of a biological product and its reference product.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Biosimilar Red Tape Elimination Act”.

HR5526 U.S. House: Biosimilar Red Tape Elimination Act